Page 17 - GPD-4-2

Gene & Protein in Disease Chinese herbs and stem cells in neurology

36. Christine CW, Richardson RM, Van Laar AD, et al. Safety 46. Horak J, Nalos L, Martinkova V, et al. Evaluation of
of AADC gene therapy for moderately advanced Parkinson mesenchymal stem cell therapy for sepsis: A randomized
disease: Three-year outcomes from the PD-1101 trial. controlled porcine study. Front Immunol. 2020;11:126.
Neurology. 2022;98(1):e40-e50.
doi: 10.3389/fimmu.2020.00126
doi: 10.1212/WNL.0000000000012952
47. Yang G, Van Kaer L. Therapeutic targeting of immune cell
37. Greene PE, Fahn S, Eidelberg D, Bjugstad KB, Breeze RE, Freed CR. autophagy in multiple sclerosis: Russian roulette or silver
Persistent dyskinesias in patients with fetal tissue transplantation bullet? Front Immunol. 2021;12:724108.
for Parkinson disease. NPJ Parkinsons Dis. 2021;7(1):38.
doi: 10.3389/fimmu.2021.724108
doi: 10.1038/s41531-021-00183-w
48. Yuan TF, Dong Y, Zhang L, et al. Neuromodulation-based
38. Wang YK, Zhu WW, Wu MH, et al. Human clinical-grade stem cell therapy in brain repair: Recent advances and future
parthenogenetic ESC-derived dopaminergic neurons perspectives. Neurosci Bull. 2021;37(5):735-745.
recover locomotive defects of nonhuman primate models of doi: 10.1007/s12264-021-00667-y
Parkinson’s disease. Stem Cell Reports. 2018;11(1):171-182.
49. Yoo DY, Nam Y, Kim W, et al. Effects of Ginkgo biloba extract
doi: 10.1016/j.stemcr.2018.05.010
on promotion of neurogenesis in the hippocampal dentate
39. Nakamura R, Nonaka R, Oyama G, et al. A defined method gyrus in C57BL/6 mice. J Vet Med Sci. 2011;73(1):71-76.
for differentiating human iPSCs into midbrain dopaminergic
progenitors that safely restore motor deficits in Parkinson’s doi: 10.1292/jvms.10-0294
disease. Front Neurosci. 2023;17:1202027. 50. Ivanova Stojcheva E, Quintela JC. The effectiveness of
Rhodiola rosea L. preparations in alleviating various aspects
doi: 10.3389/fnins.2023.1202027
of life-stress symptoms and stress-induced conditions-
40. Moon H, Kim B, Kwon I, Oh Y. Challenges involved in cell encouraging clinical evidence. Molecules. 2022;27(12):3902.
therapy for Parkinson’s disease using human pluripotent
stem cells. Front Cell Dev Biol. 2023;11:1288168. doi: 10.3390/molecules27123902
51. Shen LH, Zhang JT. Ginsenoside Rg1 promotes proliferation of
doi: 10.3389/fcell.2023.1288168
hippocampal progenitor cells. Neurol Res. 2004;26(4):422-428.
41. Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H. Efficacy and
safety of mesenchymal stem cell transplantation in the doi: 10.1179/016164104225016047
treatment of autoimmune diseases (Rheumatoid arthritis, 52. Ghaffari N, Mokhtari T, Adabi M, et al. Neurological
systemic lupus erythematosus, inflammatory bowel disease, recovery and neurogenesis by curcumin sustained‐release
multiple sclerosis, and ankylosing spondylitis): A systematic system cross‐linked with an acellular spinal cord scaffold
review and meta-analysis of randomized controlled trial. in rat spinal cord injury: Targeting NLRP3 inflammasome
Stem Cells Int. 2022;2022:9463314. pathway. Phytother Res. 2024;38:2669-2686.
doi: 10.1155/2022/9463314 doi: 10.1002/ptr.8179
42. Islam MA, Alam SS, Kundu S, et al. Mesenchymal stem cell 53. Lin TY, Lu CW, Wang CC, Wang YC, Wang SJ. Curcumin
therapy in multiple sclerosis: A systematic review and meta- inhibits glutamate release in nerve terminals from rat
analysis. J Clin Med. 2023;12(19):6311. prefrontal cortex: Possible relevance to its antidepressant
mechanism. Prog Neuropsychopharmacol Biol Psychiatry.
doi: 10.3390/jcm12196311
2011;35(7):1785-1793.
43. Bose G, Thebault S, Rush CA, Atkins HL, Freedman
MS. Autologous hematopoietic stem cell transplantation doi: 10.1016/j.pnpbp.2011.06.012
for multiple sclerosis: A current perspective. Mult Scler. 54. Daugherty DJ, Marquez A, Calcutt NA, Schubert D.
2021;27(2):167-173. A novel curcumin derivative for the treatment of diabetic
neuropathy. Neuropharmacology. 2018;129:26-35.
doi: 10.1177/1352458520917936
doi: 10.1016/j.neuropharm.2017.11.007
44. Cohen JA, Imrey PB, Planchon SM, et al. Pilot trial of
intravenous autologous culture-expanded mesenchymal 55. Attari F, Zahmatkesh M, Aligholi H, et al. Curcumin as a
stem cell transplantation in multiple sclerosis. Mult Scler. double-edged sword for stem cells: Dose, time and cell type-
2018;24(4):501-511. specific responses to curcumin. Daru. 2015;23:33.
doi: 10.1177/1352458517703802 doi: 10.1186%2Fs40199-015-0115-8
45. Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal stem 56. Farooqui AA, Farooqui T. Therapeutic potentials of curcumin
cells in multiple sclerosis: Recent evidence from pre-clinical in Parkinson’s disease. In: Curcumin for Neurological and
to clinical studies. Int J Mol Sci. 2020;21(22):8662. Psychiatric Disorders. Netherlands: Elsevier; 2019. p. 333-344.
doi: 10.3390/ijms21228662 doi: 10.1016/B978-0-12-815461-8.00018-9

Volume 4 Issue 2 (2025) 9 doi: 10.36922/gpd.4835